litlas
Log inCreate account

David O. Bates

Active 1973–2025

Also published as
David O Bates
113
Papers
18,638
Citations
82
h-index
110
i10-index

Citations

Citations per year for David O. Bates1974: 1 citations1978: 2 citations1979: 3 citations1980: 4 citations1981: 3 citations1982: 1 citations1983: 1 citations1984: 2 citations1985: 2 citations1986: 4 citations1987: 8 citations1988: 7 citations1989: 14 citations1990: 11 citations1991: 4 citations1992: 9 citations1993: 13 citations1994: 14 citations1995: 32 citations1996: 25 citations1997: 21 citations1998: 38 citations1999: 54 citations2000: 33 citations2001: 46 citations2002: 54 citations2003: 76 citations2004: 81 citations2005: 112 citations2006: 124 citations2007: 108 citations2008: 180 citations2009: 157 citations2010: 157 citations2011: 173 citations2012: 146 citations2013: 208 citations2014: 192 citations2015: 145 citations2016: 152 citations2017: 151 citations2018: 174 citations2019: 537 citations2020: 560 citations2021: 478 citations2022: 442 citations2023: 262 citations2024: 387 citations2025: 190 citations2026: 7 citations1975–1977: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,622 citing papers, 24.1% of this breakdownChina: 676 citing papers, 10% of this breakdownUnited Kingdom: 625 citing papers, 9.3% of this breakdownGermany: 387 citing papers, 5.8% of this breakdownItaly: 301 citing papers, 4.5% of this breakdownNetherlands: 235 citing papers, 3.5% of this breakdownCanada: 222 citing papers, 3.3% of this breakdownFrance: 190 citing papers, 2.8% of this breakdownSwitzerland: 183 citing papers, 2.7% of this breakdownAustralia: 179 citing papers, 2.7% of this breakdownSpain: 160 citing papers, 2.4% of this breakdownJapan: 141 citing papers, 2.1% of this breakdown
0%24.1%Other 26.8%

Institutions

Fields

  • Medicine50.4%
  • Biochemistry, Genetics and Molecular Biology32.7%
  • Neuroscience4.2%
  • Immunology and Microbiology4.2%
  • Health Professions2.2%
  • Engineering2.1%
  • Other4.2%

Topics

  • Angiogenesis and VEGF in Cancer4.6%
  • RNA Research and Splicing3%
  • RNA modifications and cancer2.7%
  • Lymphatic System and Diseases1.9%
  • Multiple Sclerosis Research Studies1.7%
  • Cancer-related molecular mechanisms research1.7%
  • Other84.4%

Coauthors

All papers

Open in search
  1. Cervical cancer in low and middle‑income countries (Review)

    Authors: Rodney Hull, Mzwandile Mbele, Tshepiso J. Makhafola, Chindo Hicks, Shaoming Wang, Rui Manuel Reis, Ravi Mehrotra, Zilungile L. Mkhize‐Kwitshana, Gibson Kibiki, David O. Bates, Zodwa Dlamini - Oncology Letters 2020 cited by 531

  2. Consensus guidelines for the use and interpretation of angiogenesis assays

    Authors: Patrycja Nowak‐Sliwinska, Kari Alitalo, Elizabeth Allen, Andrey Anisimov, Alfred C. Aplin, Robert Auerbach, Hellmut G. Augustin, David O. Bates, Judy R. van Beijnum, R. Hugh F. Bender, Gabriele Bergers, Andréas Bikfalvi, Joyce Bischoff, Barbara C. Böck, Peter C. Brooks, Federico Bussolino, Bertan Cakir, Peter Carmeliet, Daniel Castranova, Anca Maria Cîmpean, Ondine Cleaver, George Coukos, George E. Davis, Michele De Palma, Anna Dimberg, Ruud P.M. Dings, Valentin Djonov, Andrew C. Dudley, Neil Dufton, Sarah‐Maria Fendt, Napoleone Ferrara, Marcus Fruttiger, Dai Fukumura, Bart Ghesquière, Yan Gong, Robert J. Griffin, Adrian L. Harris, Christopher C.W. Hughes, Nan W. Hultgren, M. Luisa Iruela‐Arispe, Melita Irving, Rakesh K. Jain, Raghu Kalluri, Joanna Kalucka, Robert S. Kerbel, Jan Kitajewski, Ingeborg Klaassen, Hynda K. Kleinmann, Pieter Koolwijk, Elisabeth Kuczynski, Brenda R. Kwak, Koen M. Marien, Juan M. Melero‐Martin, Lance L. Munn, Roberto F. Nicosia, Agnès Noël, Jussi Nurro, Anna-Karin Olsson, Tatiana V. Petrova, Kristian Pietras, Роберто Пили, Jeffrey W. Pollard, Mark J. Post, Paul H.A. Quax, Gabriel A. Rabinovich, Marius Raica, Anna M. Randi, Doménico Ribatti, Curzio Rüegg, Reinier O. Schlingemann, Stefan Schulte‐Merker, Lois E. H. Smith, Jonathan W. Song, Steven A. Stacker, Jimmy Stalin, Amber N. Stratman, Maureen Van de Velde, Victor W.M. van Hinsbergh, Peter Vermeulen, Johannes Waltenberger, Brant M. Weinstein, Hong Xin, Bahar Yetkin-Arik, Seppo Ylä‐Herttuala, Mervin C. Yöder, Arjan W. Griffioen - Angiogenesis 2018 cited by 597

  3. Hallmarks of alternative splicing in cancer

    Authors: Sebastian Oltean, David O. Bates - Oncogene 2013 cited by 701

  4. An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance

    Authors: Ningning Li, Roya Babaei‐Jadidi, Federica Lorenzi, Bradley Spencer‐Dene, Philip A. Clarke, Enric Domingo, Eugene Tulchinsky, Robert G.J. Vries, David Kerr, Yihang Pan, Yulong He, David O. Bates, Ian Tomlinson, Hans Clevers, Abdolrahman S. Nateri - Oncogenesis 2019 cited by 150

  5. Vascular endothelial growth factors and vascular permeability

    Authors: David O. Bates - Cardiovascular Research 2010 cited by 518

  6. Loss of the Endothelial Glycocalyx Links Albuminuria and Vascular Dysfunction

    Authors: Andrew Salmon, Joanne Ferguson, James L. Burford, Haykanush Gevorgyan, Daisuke Nakano, Steven J. Harper, David O. Bates, János Peti‐Peterdi - Journal of the American Society of Nephrology 2012 cited by 265

  7. Local microvascular leakage promotes trafficking of activated neutrophils to remote organs

    Authors: Charlotte Owen-Woods, Régis Joulia, Anna Barkaway, Loïc Rolas, Bin Ma, Astrid F. Nottebaum, Kenton P. Arkill, Monja Stein, Tamara Girbl, Matthew Golding, David O. Bates, Dietmar Vestweber, Mathieu-Benoı̂t Voisin, Sussan Nourshargh - Journal of Clinical Investigation 2020 cited by 74

  8. VEGF-A splicing: the key to anti-angiogenic therapeutics?

    Authors: Steven J. Harper, David O. Bates - Nature reviews. Cancer 2008 cited by 510

  9. Sialic acids regulate microvessel permeability, revealed by novel in vivo studies of endothelial glycocalyx structure and function

    Authors: Kai Betteridge, Kenton P. Arkill, Christopher R. Neal, Steven J. Harper, Rebecca R. Foster, Simon C. Satchell, David O. Bates, Andrew Salmon - The Journal of Physiology 2017 cited by 125

  10. The mutant p53‐ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1

    Authors: Magdalena Pruszko, Elisa Milano, Mattia Forcato, Sara Donzelli, Federica Ganci, Silvia Di Agostino, Simone De Panfilis, Francesco Fazi, David O Bates, Silvio Bicciato, Maciej Żylicz, Maciej Żylicz, Giovanni Blandino, Giulia Fontemaggi - EMBO Reports 2017 cited by 109

  11. IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia

    Authors: WU Wei-kang, Oliver Llewellyn, David O. Bates, Lindsay B. Nicholson, Andrew D. Dick - Immunobiology 2010 cited by 183

  12. Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels

    Authors: Abbas Dehghan, Josée Dupuis, Maja Barbalić, Joshua C. Bis, Guðný Eiríksdóttir, Lu Chen, Niina Pellikka, Henri Wallaschofski, Johannes Kettunen, Peter Henneman, Jens Baumert, David P. Strachan, Christian Fuchsberger, Véronique Vitart, James F. Wilson, Guillaume Paré, Silvia Naitza, Megan E. Rudock, Ida Surakka, Eco J. C. de Geus, Behrooz Z. Alizadeh, Jack M. Guralnik, Alan R. Shuldiner, Toshiko Tanaka, Robert Y.L. Zee, Renate B. Schnabel, Vijay Nambi, Maryam Kavousi, Samuli Ripatti, Matthias Nauck, Nicholas L. Smith, Albert V. Smith, Jouko Sundvall, Paul Scheet, Ching‐Ti Liu, Aimo Ruokonen, Lynda M. Rose, Martin G. Larson, Ron C. Hoogeveen, Nelson B. Freimer, Alexander Teumer, Russell P. Tracy, Lenore J. Launer, Julie E. Buring, Jennifer F. Yamamoto, Aaron R. Folsom, Eric J.G. Sijbrands, James S. Pankow, Paul Elliott, John F. Keaney, Wei Sun, Antti-Pekka Sarin, João D. Fontes, Sunita Badola, Brad C. Astor, Albert Hofman, Anneli Pouta, Karl Werdan, Karin Halina Greiser, Oliver Kuß, Henriette E. Meyer zu Schwabedissen, Joachim Thiery, Yalda Jamshidi, Ilja M. Nolte, Nicole Soranzo, Timothy D. Spector, Henry Völzke, Alexander N. Parker, Thor Aspelund, David O. Bates, Lauren Young, Kim Tsui, David S. Siscovick, Xiuqing Guo, Jerome I. Rotter, Manuela Uda, David Schlessinger, Igor Rudan, Andrew A. Hicks, Brenda W.J.H. Penninx, Barbara Thorand, Christian Gieger, Joe Coresh, Gonneke Willemsen, Tamara B. Harris, André G. Uitterlinden, Marjo‐Riitta Järvelin, Kenneth Rice, Dörte Radke, Veikko Salomaa, Ko Willems van Dijk, Eric Boerwinkle, Ramachandran S. Vasan, Luigi Ferrucci, Quince Gibson, Stefania Bandinelli, Harold Snieder, Dorret I. Boomsma, Xiangjun Xiao, Harry Campbell and 14 more - Circulation 2011 cited by 524

  13. Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis

    Authors: Shaney Barratt, Thomas Blythe, Caroline Jarrett, Khadija Ourradi, Golda Shelley‐Fraser, Michael Day, Yan Qiu, Steve Harper, Toby M. Maher, Sebastian Oltean, Thomas J. Hames, Chris J. Scotton, Gavin I. Welsh, David O. Bates, Ann Millar - American Journal of Respiratory and Critical Care Medicine 2017 cited by 83

  14. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

    Authors: Dawid G. Nowak, Jeanette Woolard, Elianna Amin, Olga Konopatskaya, Moin A. Saleem, A Churchill, Michael Ladomery, Steven J. Harper, David O. Bates - Journal of Cell Science 2008 cited by 341

  15. An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

    Authors: Ryosuke Kikuchi, Kazuto Nakamura, Susan MacLauchlan, Doan Thi-Minh Ngo, Ippei Shimizu, José J. Fuster, Yasufumi Katanasaka, Sumiko Yoshida, Yan Qiu, Terry P. Yamaguchi, Tadashi Matsushita, Toyoaki Murohara, Noyan Gokce, David O Bates, Naomi M. Hamburg, Kenneth Walsh - Nature Medicine 2014 cited by 197

  16. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion

    Authors: Mussarat Wahid, Benjamart Pratoomthai, Isioma U. Egbuniwe, Hannah Evans, Roya Babaei‐Jadidi, Jason Amartey, V. Erdélyi, Kiren Yacqub‐Usman, Andrew M. Jackson, Jonathan C. Morris, Poulam M. Patel, David O. Bates - Cancer Immunology Immunotherapy 2023 cited by 25

  17. Successfully Implementing Digital Health to Ensure Future Global Health Security During Pandemics

    Authors: Bandar Al Knawy, Mollie M. McKillop, Joud Abduljawad, Sasu Tarkoma, Mahmood Adil, Louise Schaper, Adam Chee, David O. Bates, Michael J. Klag, Uichin Lee, Zisis Kozlakidis, George Crooks, Kyu Rhee - JAMA Network Open 2022 cited by 57

  18. Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts

    Authors: Benjamin P. Sharpe, Annette Hayden, Antigoni Manousopoulou, Andrew Cowie, Robert Walker, Jack Harrington, Fereshteh Izadi, Stella P. Breininger, Jane Whitney Gibson, Oliver Pickering, Eleanor Jaynes, Ewan Kyle, J. Saunders, Simon L. Parsons, Alison Ritchie, Philip A. Clarke, Pamela Collier, Nigel P. Mongan, David O. Bates, Kiren Yacqub‐Usman, Spiros D. Garbis, Zoë S. Walters, Matthew Rose‐Zerilli, Anna M. Grabowska, Tim Underwood - Cell Reports Medicine 2022 cited by 24

  19. WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing

    Authors: Elianna Amin, Sebastian Oltean, Jing Hua, Melissa V. Gammons, Maryam Hamdollah‐Zadeh, Gavin I. Welsh, Man‐Kim Cheung, Lan Ni, Yoshihiro Matsuno, Emma Rennel, Kirsty E. Symonds, Dawid G. Nowak, Brigitte Royer‐Pokora, Moin A. Saleem, Masatoshi Hagiwara, Valerié Schumacher, Steven J. Harper, David R. Hinton, David O. Bates, Michael Ladomery - Cancer Cell 2011 cited by 249

  20. Phenotypic and functional translation of IL33 genetics in asthma

    Authors: Maria E. Ketelaar, Michael A. Portelli, F. Nicole Dijk, Nick Shrine, Alen Faiz, Cornelis J. Vermeulen, Cheng‐Jian Xu, Jenny Hankinson, Sangita Bhaker, Amanda P. Henry, C.K. Billington, Dominick Shaw, Simon R. Johnson, Andrew V. Benest, Vincent Pang, David O. Bates, Zara Pogson, Andrew Fogarty, Tricia M. McKeever, Amisha Singapuri, Liam G. Heaney, Adel Mansur, Rekha Chaudhuri, Neil C. Thomson, John W. Holloway, Gabrielle A. Lockett, Peter Howarth, Robert Niven, Angela Simpson, Martin D. Tobin, Ian P. Hall, Louise V. Wain, John Blakey, Christopher E. Brightling, Ma’en Obeidat, Don D. Sin, David C. Nickle, Yohan Bossé, Judith M. Vonk, Maarten van den Berge, Gerard H. Koppelman, Ian Sayers, Martijn C. Nawijn - Journal of Allergy and Clinical Immunology 2020 cited by 49

  21. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes

    Authors: Monica Gamez, Hesham E. Elhegni, Sarah Fawaz, Kwan Ho Ho, Neill Campbell, David A. Copland, Karen L. Onions, Matthew Butler, Elizabeth J. Wasson, Michael Crompton, Raina Ramnath, Yan Qiu, Yu Yamaguchi, Kenton P. Arkill, David O. Bates, Jeremy E. Turnbull, Olga V. Zubkova, Gavin I. Welsh, Denize Atan, Simon C. Satchell, Rebecca R. Foster - Cardiovascular Diabetology 2024 cited by 25

  22. Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms

    Authors: Dawid G. Nowak, Elianna Amin, Emma Rennel, Coralie Hoareau‐Aveilla, Melissa V. Gammons, Gopinath Damodoran, Masatoshi Hagiwara, Steven J. Harper, Jeanette Woolard, Michael Ladomery, David O. Bates - Journal of Biological Chemistry 2009 cited by 222

  23. Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity

    Authors: Jeanette Woolard, Heather S. Bevan, Steven J. Harper, David O. Bates - Microcirculation 2009 cited by 150

  24. Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease

    Authors: Jennifer Batson, Hamish D. Toop, Clara Redondo, Roya Babaei‐Jadidi, A. Chaikuad, S. Wearmouth, Brian Gibbons, Claire Allen, C. Tallant, Jingxue Zhang, Chunyun Du, Jules C. Hancox, Tom Hawtrey, Joana Rocha, Renate Griffith, Stefan Knapp, David O. Bates, Jonathan C. Morris - ACS Chemical Biology 2017 cited by 108